Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1982-01-03
1984-08-14
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31135
Patent
active
044656920
ABSTRACT:
A method of selectively stimulating D-2 dopamine receptors in humans comprising administering to a human requiring D-2 dopamine receptor stimulation, a therapeutically effective amount of 2-(N-phenylethyl-N-propylamino)-5-hydroxytetralin or a pharmaceutically acceptable salt thereof.
REFERENCES:
Hacksell et al., J. Med. Chem. 22, (1979), 1469-1475.
Sumners et al., Arch. Pharmacol. 316, (1981), 304-310.
Friedman Stanley J.
Nelson Research & Development Company
LandOfFree
Selective D-2 dopamine receptor agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective D-2 dopamine receptor agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective D-2 dopamine receptor agonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-114051